Wbh Advisory Inc Eli Lilly & CO Transaction History

Wbh Advisory Inc

$964 Million
Q1 2024

A detailed history of Wbh Advisory Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Wbh Advisory Inc holds 10,273 shares of LLY stock, worth $9.43 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

10,273

Previous 10,918 5.91%

Holding current value

$9.43 Million

Previous $6.36 Million 25.57%

% of portfolio

0.83%

Previous 0.71%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$592.2 - $792.28 $381,969 - $511,020	-645 Reduced 5.91%	10,273 $7.99 Million
Q4 2023 Jan 09, 2024	SELL	$525.19 - $619.13 $105,038 - $123,826	-200 Reduced 1.8%	10,918 $6.36 Million
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $163,012 - $224,737	-375 Reduced 3.26%	11,118 $5.97 Million
Q2 2023 Jul 12, 2023	SELL	$350.74 - $468.98 $106,274 - $142,100	-303 Reduced 2.57%	11,493 $5.39 Million
Q1 2023 Apr 20, 2023	SELL	$310.63 - $364.82 $162,459 - $190,800	-523 Reduced 4.25%	11,796 $4.05 Million

Q3 2022 Oct 18, 2022	SELL	$296.48 - $337.87 $26,090 - $29,732	-88 Reduced 0.71%	12,319 $3.98 Million
Q2 2022 Jul 12, 2022	SELL	$278.73 - $327.27 $34,562 - $40,581	-124 Reduced 0.99%	12,407 $4.11 Million
Q1 2022 Apr 29, 2022	SELL	$234.69 - $291.66 $158,181 - $196,578	-674 Reduced 5.1%	12,531 $3.59 Million
Q4 2021 Jan 28, 2022	SELL	$224.85 - $279.04 $62,508 - $77,573	-278 Reduced 2.06%	13,205 $3.65 Million
Q3 2021 Oct 25, 2021	SELL	$221.6 - $272.71 $65,372 - $80,449	-295 Reduced 2.14%	13,483 $3.12 Million
Q2 2021 Jul 27, 2021	SELL	$180.55 - $233.54 $17,693 - $22,886	-98 Reduced 0.71%	13,778 $3.35 Million
Q1 2021 Apr 19, 2021	SELL	$164.32 - $212.72 $63,591 - $82,322	-387 Reduced 2.71%	13,876 $2.59 Million
Q4 2020 Jan 21, 2021	SELL	$130.46 - $172.63 $1,695 - $2,244	-13 Reduced 0.09%	14,263 $2.87 Million
Q3 2020 Oct 27, 2020	SELL	$146.22 - $169.13 $22,810 - $26,384	-156 Reduced 1.08%	14,276 $2.11 Million
Q2 2020 Aug 05, 2020	BUY	$136.42 - $164.18 $4,501 - $5,417	33 Added 0.23%	14,432 $2.37 Million
Q1 2020 May 07, 2020	BUY	$119.05 - $147.35 $5,714 - $7,072	48 Added 0.33%	14,399 $2 Million
Q4 2019 Jan 27, 2020	SELL	$106.92 - $132.43 $7,698 - $9,534	-72 Reduced 0.5%	14,351 $1.89 Million
Q3 2019 Oct 25, 2019	SELL	$106.79 - $116.16 $9,611 - $10,454	-90 Reduced 0.62%	14,423 $1.61 Million
Q2 2019 Aug 02, 2019	SELL	$110.79 - $129.32 $6,315 - $7,371	-57 Reduced 0.39%	14,513 $1.61 Million
Q1 2019 Apr 22, 2019	SELL	$111.31 - $131.02 $22,373 - $26,335	-201 Reduced 1.36%	14,570 $1.89 Million
Q4 2018 Jan 29, 2019	SELL	$105.9 - $118.64 $14,084 - $15,779	-133 Reduced 0.89%	14,771 $1.71 Million
Q3 2018 Oct 29, 2018	BUY	$85.86 - $107.31 $62,677 - $78,336	730 Added 5.15%	14,904 $1.6 Million
Q2 2018 Jul 31, 2018	BUY	$75.7 - $86.88 $24,375 - $27,975	322 Added 2.32%	14,174 $1.21 Million
Q1 2018 Apr 30, 2018	SELL	$74.21 - $87.6 $47,049 - $55,538	-634 Reduced 4.38%	13,852 $1.07 Million
Q4 2017 Jan 31, 2018	SELL	$81.94 - $87.89 $46,787 - $50,185	-571 Reduced 3.79%	14,486 $1.23 Million
Q3 2017 Nov 29, 2017	BUY	$77.07 - $85.54 $1.16 Million - $1.29 Million	15,057	15,057 $1.29 Million

Others Institutions Holding LLY

# of Institutions

3,727

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $872B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wbh Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wbh Advisory Inc with notifications on news.

Account